Health · 3 views
Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins
Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations.
Summary
Auditory hallucinations—or hearing voices that others do not hear—affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- AI measurements of heart scans more strongly linked to patient survival than clinician measurementsContinue reading
- Novel Therapy Lands Speedy Approval for Wart-Like Airway DiseaseContinue reading
- Study Strengthens Case for Stent-Free PCI in De Novo Coronary LesionsContinue reading
- CTE in NFL Players: What a New Study Tells Us -- And What It Doesn'tContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow